Organon Korea said Thursday that Organon, a spinoff of Merck, has officially launched as a differentiated global healthcare company focusing on women’s health.Organon Korea, as a local offshoot of Organon, has prepared for the shift since February. “Based on market-leading products treating chronic
Icure Pharmaceutical recently obtained the Ministry of Food and Drug Safety’s nod to export patch-type donepezil, a treatment for Alzheimer’s disease.The export approval is expected to speed up the shipment of the patch to China in particular, as the company signed a deal to supply the product to Ch
Multinational pharmaceutical companies’ local offshoots are actively reducing workforce amid the prolonged Covid-19 pandemic, industry watchers said.In the first half of this year, the Korean branches of Viatris, GSK, Astellas, Zuellig Pharma, Janssen, and Roche, have announced the so-called early r
T&R Biofab, a company specializing in 3D bioprinting, said Thursday that it has signed a deal with Epibiotech, a new drug candidate material developer, to co-develop hair loss treatment using induced pluripotent stem cells.T&R Biofab and Epibiotech plan to establish a co-development system and promo
GSK said Wednesday that Trelegy Ellipta (ingredient: fluticasone furoate, umeclidinium, vilanterol), a triple inhaled therapy that reduces the mortality rate of chronic obstructive pulmonary disease (COPD) patients, has begun to receive insurance benefits from this month.At an online conference to c
Hanall Biopharma said Wednesday that Immunovant, its U.S. partner, has recently decided to resume the clinical trial of HL161, an autoimmune disease treatment.In February, Immunovant voluntarily suspended the clinical trials of HL161, known as IMVT-1401 in the U.S., due to an increase in cholesterol
Bridge Biotherapeutics said it began administering BBT-401, an ulcerative colitis drug candidate, to investigate the mechanism of action of a new method in clinical trials in New Zealand on Tuesday.The company aims to check the safety and efficacy of the new way of giving BBT-401 with six active ulc
The pharmaceutical industry is paying attention to whether Janssen’s Imbruvica (ingredient: ibrutinib) plus Abbvie's Venclexta (venetoclax) will become a new treatment option in blood cancer.At the American Society of Clinical Oncology (ASCO 2021) online meeting from Friday to Tuesday next week, com
The pace of the Covid-19 vaccination program is accelerating in Korea.Since late May, the health authorities allowed non-priority people to receive leftover Covid-19 vaccines, made available from canceled appointments or uses of low dead space syringes.Just in three months after the vaccination star
Pfizer Korea denied a media report on Tuesday concerning the Daegu Metropolitan Government’s push to introduce Pfizer's Covid-19 vaccine separately from the central government."Amid the Covid-19 pandemic, Pfizer is supplying its Covid-19 vaccines to only central governments and state regulators," a
Amgen has recently obtained the first-ever FDA approval for sotorasib (brand name: Lumakras), a treatment for KRAS G12-mutated non-small cell lung cancer (NSCLC).NSCLC with KRAS mutation has remained untreated for over 40 years.On Friday, the FDA approved the use of sotorasib, an oral KRAS G12C inhi
ST Pharm said it would develop the nation’s first lipid nanoparticle (LNP)-based Covid-19 mRNA vaccine that can respond to variant cases.In developing the vaccine, the company plans to apply Genevant Science's LNP technology, used in developing Pfizer and Moderna's mRNA vaccine, and its patented 5’-
Large Korean biopharmaceutical companies have released their financial reports for the first quarter, demonstrating mixed performances.Some companies began to recover from the Covid-19’s fallout that has lasted for more than a year, while others remained in the doldrum for various reasons.Samsung Bi
Korean pharmaceutical companies are rushing to enter the pet treatment market, focusing R&D particularly on diseases like diabetes and cognitive impairment from which old pets tend to suffer.In 2019, 5.9 million Korean households, or 26.4 percent of the total, raised a pet. Industry officials said t
Local pharmaceutical companies are expediting the development of antidepressants as more people suffer from anxiety and depression amid the coronavirus pandemic.According to a survey by Korea Health Promotion Institute, 40.7 percent of the respondents said they experienced anxiety and depression bec
AstraZeneca said Monday that the Ministry of Food and Drug Safety has approved Koselugo (ingredient: selumetinib) for treating pediatric patients with neurofibromatosis type 1 (NF1) above three years old.The Korean regulator approved the drug to treat NF1 patients accompanying plexiform neurofibroma
GSK and Vir Biotechnology said Friday that their Covid-19 drug candidate VIR-7831 has received emergency use authorization (EUA) from the U.S. Food and Drug Administration. FDA granted the EUA for the single monoclonal antibody candidate developed by GSK and Vir to treat and prevent mild and moderat
Novartis Korea said Friday that the Ministry of Food and Drug Safety has approved Zolgensma, gene therapy for spinal muscular atrophy (SMA).Hospitals can use the drug to treat SMA Type 1 patients with a double allelic mutation in the SMN1 gene or three or fewer copies of the SMN Type 2 gene.The mini
Novo Nordisk and Sanofi Aventis, the two dominant insulin providers in Korea, have shown mixed sales performances in the first quarter.According to IQVIA, a drug market research company, Novo Nordisk finally surpassed Sanofi in the first three months, as Tresiba and Ryzodeg generated robust sales in
The European Medicines Agency’s (EMA) Committee for Human Medical Products (CHMP) issued a positive scientific opinion on sotrovimab, a Covid-19 treatment candidate developed by GSK and Vir Biotechnology, GSK said.The CHMP’s evaluation involved the use of sotrovimab for adults and adolescents (aged